The Head and Neck Cancer market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Head and Neck Cancer: An Overview
Head and Neck Cancers usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck (for example, inside the mouth, the nose, and the throat). These squamous cell cancers are often referred to as squamous cell carcinoma of Head and Neck Cancer.
Cancer cells can spread to other parts of the body. Cancer cells in the head or neck can sometimes travel to the lungs and grow there. When cancer cells do this, it’s called metastasis. Patients who demonstrate the growth of cancer outside of the original head and neck site or lymph nodes of the head and neck have developed distant metastases, and are considered to have an incurable disease. Diagnosis of head and neck cancers usually involves several tests to help determine the stage of cancer.
Head and Neck Cancer Market Key Facts
As per World Health Organisation (WHO) (2014), Head and Neck Cancer encompasses many site-specific cancers, including oral cavity and oropharyngeal cancers. Studies have estimated the global incidence of all Metastatic Head and Neck Cancers to be between 400,000 and 600,000 new cases per year and the mortality rate to between 223,000 and 300,000 deaths per year.
Most HNSCCs arise in the hypopharynx, larynx, trachea, oral cavity and oropharynx. The majority of laryngeal SCCs originate from the supraglottic and glottic regions. Tracheal SCCs are rare compared to laryngeal ones. The most common oropharyngeal site of involvement is the base of the tongue. Within the oral cavity, most tumors arise from the floor of the mouth, the ventrolateral tongue or the soft palate complex.
As per the American Dental Association 2020: Squamous cell carcinoma (SCC) is the most common malignancy in the oral cavity (OC) and oropharynx (OP), accounting for 90% of cancers of the head and neck. OC and OP cancers account for 2.9% of all cancers diagnosed in the U.S. and 1.6% of all cancer deaths.
Head and Neck Cancer Market
Head and Neck Cancer market size is anticipated to increase during the study period owing to the rise in the incident cases in the 7MM. The expected launch of the pipeline therapies will also fuel the growth of the market.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Head and Neck Cancer market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Head and Neck Cancer market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Head and Neck Cancer Epidemiology
The epidemiology section covers insights about the historical and current Head and Neck Cancer patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Head and Neck cancer (HNC) Epidemiology Segmentation –
Incident cases of Head and Neck Cancer (HNC)
Gender-specific Incident Cases of Head and Neck Cancer
Age-specific incident Cases of Head and Neck Cancer
Site-specific incident Cases of Head and Neck Cancer
Stage-specific incident Cases of Head and Neck Cancer
Head and Neck Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Head and Neck Cancer market or expected to get launched in the market during the study period. The analysis covers Head and Neck Cancer market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Head and Neck Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market
Head and Neck Cancer Therapeutics Analysis
The research and development of new treatment therapies for Head and Neck Cancer are categorized into various groups. The dynamics of the Head and Neck Cancer market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and also the expected launch of emerging therapies.
Some of the key companies in the Head and Neck cancer (HNC) Market include:
CueBio
Merck
Boehringer Ingelheim
Sensei Biotherapeutics
PDS Biotechnology Corporation
Iovance Biotherapeutics
And many others
Head and Neck cancer (HNC) therapies covered in the report include:
PDS0101
LN-145
CUE-101
SNS-301
BIBW2992
Immutep
And many more.
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market
Table of Content
1. Key Insights
2. Executive Summary
3. Head and Neck Cancer Competitive Intelligence Analysis
4. Head and Neck Cancer Market Overview at a Glance
5. Head and Neck Cancer Disease Background and Overview
6. Head and Neck Cancer Patient Journey
7. Head and Neck Cancer Epidemiology and Patient Population
8. Head and Neck Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Head and Neck Cancer Unmet Needs
10. Key Endpoints of Head and Neck Cancer Treatment
11. Head and Neck Cancer Marketed Products
12. Head and Neck Cancer Emerging Therapies
13. Head and Neck Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Head and Neck Cancer Market Outlook (7 major markets)
16. Head and Neck Cancer Access and Reimbursement Overview
17. KOL Views on the Head and Neck Cancer Market.
18. Head and Neck Cancer Market Drivers
19. Head and Neck Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/head-and-neck-cancer-hnc-market
Other Latest Reports By DelveInsight
Asthma Diagnostic Devices Market
DelveInsight’s “Asthma Diagnostic Devices Market” report delivers an in-depth understanding of Asthma Diagnostic Devices, the historical and forecasted Asthma Diagnostic Devices market size, share, trends in North America, Europe, APAC, and RoW, as well as the emerging devices and key companies operating in the domain.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/
